Search Within

Filemon Dela Cruz

Formats
  1. Meeting Abstract (31)
  2. Journal Article (28)
  3. Editorial (2)
  4. Review (1)
Groups
  1. Pediatrics, Department of (62)
  2. Sarcoma Service (Pediatrics) (62)
  3. Center for Hematologic Malignancies (45)
  4. Tow Center for Developmental Oncology (TCDO) (43)
  5. Executive Committee, Center for Hematologic Malignancies (41)
  6. Stem Cell Transplantation and Cellular Therapy Service (41)

More Groups

People
  1. Andrew Kung (41)
  2. Daoqi You (16)
  3. Julia Glade Bender (16)
  4. Michael Ortiz (14)
  5. Emily Slotkin (13)
  6. Glorymar Ibanez Sanchez (12)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (10)
  3. Pediatric Blood and Cancer (8)
  4. Cancer Discovery (3)
  5. Nature Communications (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (12)
  3. Wiley Periodicals, Inc (8)
  4. Nature Publishing Group (7)
  5. Elsevier Inc. (3)
  6. Nature Research (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A systems biology approach to reprogramming drug-resistant breast cancer stem-like cells
    Meeting Abstract

    Worley, J.; Ding, H.; Noh, H.; Paull, E.; Bush, E.; Dalerba, P.; Sims, P.; Dela Cruz, F.; Kung, A.; Califano, A.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Preclinical evaluation of XPO1 inhibition in Wilms tumors
    Meeting Abstract

    Ortiz, M. V.; Siddiquee, A.; You, D.; Mundi, P. S.; Marks, L.; Guillan, K.; Diolaiti, D.; Aburi, M.; Califano, A.; Dela Cruz, F. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors
    Meeting Abstract

    Dela Cruz, F. S.; Fox, E.; Muscal, J. A.; Kirov, I.; Geller, J. I.; DuBois, S. G.; Kim, A.; Croop, J.; Laetsch, T. W.; Minard, C. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • OSTPDL1: A phase II study of avelumab, a monoclonal antibody targeting programmed death-ligand 1 (PD-L1) in adolescent and young adult patients with recurrent or progressive osteosarcoma
    Meeting Abstract

    Bishop, M. W.; Kaste, S. C.; Sykes, A.; Pan, H.; Dela Cruz, F. S.; Whittle, S.; Mascarenhas, L.; Thomas, P. G.; Youngblood, B.; Harman, J. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082)
    Meeting Abstract

    Gaspar, N.; Campbell-Hewson, Q.; Bielack, S. S.; Campbell, M.; Bautista, F.; Meazza, C.; Janeway, K.; Dela Cruz, F. S.; Whittle, S. B.; Morgenstern, D. A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clonal evolution of chemotherapy-resistant rhabdomyosarcoma via multifocal genomic analysis of pretreatment and treatment-resistant autopsy specimens
    Meeting Abstract

    Kinnaman, M. D.; Makohon-Moore, A.; Bouvier, N.; Glodzik, D.; Levine, M.; Papaemmanuil, E.; Dela Cruz, F.; Wexler, L.; Kung, A.; Iacobuzio-Donahue, C.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clonal evolution in metastatic rhabdomyosarcoma
    Meeting Abstract

    Kinnaman, M.; Makohon-Moore, A.; Bouvier, N.; Glodzik, D.; Levine, M.; Papaemmanuil, E.; Dela Cruz, F.; Wexler, L.; Kung, A.; Iacobuzio-Donahue, C.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel AKT1 fusion-driven cancer
    Journal Article

    Slotkin, E. K.; Diolaiti, D.; Shukla, N. N.; Dela Cruz, F. S.; Clark, J. J.; Gundem, G.; Yellapantula, V. D.; Levine, M. F.; You, D.; Ma, P.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Local drug activation technology to make cytotoxics safer for localized solid tumors
    Meeting Abstract

    Srinivasan, S.; Yee, N.; Dela Cruz, F.; Kung, A.; Gaviria, E.; Miller, E.; Royzen, M.; Oneto, J. M. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save